| VPRIV |
022575 |
002 |
351(a) |
velaglucerase alfa |
For Injection |
Intravenous |
200UNITS |
Single-Dose Vial |
2010/02/26
|
Takeda Pharmaceuticals U.S.A., Inc. |
Disc |
Licensed |
N/A |
N/A |
| Prevnar 13 |
125324 |
001 |
351(a) |
Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2010/02/24
|
Wyeth Pharmaceuticals LLC |
Disc |
Licensed |
|
N/A |
| Menveo |
125300 |
001 |
351(a) |
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
Injection |
Intramuscular |
0.5ML |
Single-Dose Vial |
2010/02/19
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Xiaflex |
125338 |
001 |
351(a) |
collagenase clostridium histolyticum |
For Injection |
Intralesional |
0.9MG |
Single-Dose Vial |
2010/02/02
|
Auxilium Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Actemra |
125276 |
001 |
351(a) |
tocilizumab |
Injection |
Intravenous |
80MG/4ML (20MG/ML)
|
Single-Dose Vial |
2010/01/08
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Actemra |
125276 |
002 |
351(a) |
tocilizumab |
Injection |
Intravenous |
200MG/10ML (20MG/ML) |
Single-Dose Vial |
2010/01/08
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Actemra |
125276 |
003 |
351(a) |
tocilizumab |
Injection |
Intravenous |
400MG/20ML (20MG/ML) |
Single-Dose Vial |
2010/01/08
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Stelara |
125261 |
003 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
45MG/0.5ML |
Pre-Filled Syringe |
2009/12/30
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Stelara |
125261 |
004 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
90MG/ML |
Pre-Filled Syringe |
2009/12/30
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
003 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
180 UG/.5ML |
Pre-Filled Syringe |
2009/12/23
|
Sanofi Pasteur Inc. |
Rx |
Licensed |
|
N/A |
| Kalbitor |
125277 |
001 |
351(a) |
ecallantide |
Injection |
Subcutaneous |
10MG/ML |
Single-Dose Vial |
2009/12/01
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Agriflu |
125297 |
001 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
.05ML |
Syringe |
2009/11/27
|
Seqirus Inc. |
Disc |
Licensed |
|
N/A |
| Flulaval, Flulaval Quadrivalent |
125163 |
002 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
15UG/.5ML |
Multi-Dose Vial |
2009/11/10
|
ID Biomedical Corporation of Quebec |
Disc |
Licensed |
|
N/A |
| Arzerra |
125326 |
001 |
351(a) |
ofatumumab |
Injection |
Intravenous |
100MG/5ML |
Single-Dose Vial |
2009/10/26
|
Novartis Pharmaceuticals Corporation |
Disc |
Licensed |
N/A |
N/A |
| Cervarix |
125259 |
001 |
351(a) |
Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2009/10/16
|
GlaxoSmithKline Biologicals |
Disc |
Licensed |
|
N/A |
| Berinert |
125287 |
001 |
351(a) |
C1 Esterase Inhibitor (Human) |
For Injection |
Intravenous |
500U |
Single-Dose Vial |
2009/10/09
|
CSL Behring GmbH |
Rx |
Licensed |
|
N/A |
| Privigen |
125201 |
004 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
2.5G |
Single-Dose Vial |
2009/10/02
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Stelara |
125261 |
001 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
45MG/0.5ML |
Single-Dose Vial |
2009/09/25
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Stelara |
125261 |
002 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
90MG/ML |
Single-Dose Vial |
2009/09/25
|
Janssen Biotech, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Evithrom |
125247 |
004 |
351(a) |
Thrombin, Topical (Human) |
For Injection |
Topical |
1600-2400IU/ML |
Single-dose vial |
2009/09/17
|
Omrix Biopharmaceuticals Ltd |
Rx |
Licensed |
|
N/A |